Pleural Effusion, Malignant [clinicaltrials_resource:0224c87232a56166bc8710b8dcb1c554]
Non-small Cell Lung Cancer Registry [clinicaltrials:NCT00099541]Multiple Biomarkers in Undiagnosed Pleural Effusion [clinicaltrials:NCT00316134]clinicaltrials:NCT00978939Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural Effusion [clinicaltrials:NCT01670786]Relationship Between Pleural Elastance and Effectiveness of Pleurodesis on Recurrent Malignant Pleural Effusion [clinicaltrials:NCT01819363]Multicentre Study Comparing Indwelling Pleural Catheter With Talc Pleurodesis for Malignant Pleural Effusion Management [clinicaltrials:NCT02045121]clinicaltrials:NCT02250118Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer [clinicaltrials:NCT02407912]Out Patient Talc Slurry Via Indwelling Pleural Catheter for Malignant Pleural Effusion Vs Usual Inpatient Management [clinicaltrials:NCT02517749]
condition [clinicaltrials_vocabulary:condition]
clinicaltrials:NCT00002622Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions [clinicaltrials:NCT00002872]Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]clinicaltrials:NCT00042770Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer [clinicaltrials:NCT00052338]Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions [clinicaltrials:NCT00066404]Non-small Cell Lung Cancer Registry [clinicaltrials:NCT00099541]Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion [clinicaltrials:NCT00114205]Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00118183]A Quality of Life Study re Management of Malignant Pleural Effusions [clinicaltrials:NCT00188474]clinicaltrials:NCT00215930clinicaltrials:NCT00231465Comparison the Level of CTGF Protein and Related Cytokine in Pleural Effusion [clinicaltrials:NCT00313066]Multiple Biomarkers in Undiagnosed Pleural Effusion [clinicaltrials:NCT00316134]clinicaltrials:NCT00402896Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00408460]A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis [clinicaltrials:NCT00430664]clinicaltrials:NCT00528645clinicaltrials:NCT00533585clinicaltrials:NCT00564733Tunneled Pleural Catheter in Partially Entrapped Lung [clinicaltrials:NCT00637676]Ibuprofen or Morphine in Treating Pain in Patients Undergoing Pleurodesis for Malignant Pleural Effusion [clinicaltrials:NCT00644319]Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment [clinicaltrials:NCT00752076]A Prospective, Randomized Controlled Trial for a Rapid Pleurodesis Protocol for the Management of Pleural Effusions [clinicaltrials:NCT00758316]Talc Pleurodesis in Patients With Recurrent Malignant Pleural Effusion [clinicaltrials:NCT00789087]The First Therapeutic Intervention in Malignant Pleural Effusion Trial [clinicaltrials:NCT00896285]Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer [clinicaltrials:NCT00897143]clinicaltrials:NCT00978939clinicaltrials:NCT01004510Pleural Catheters Versus Thoracoscopic Pleurodesis [clinicaltrials:NCT01117740]clinicaltrials:NCT01125124clinicaltrials:NCT01256801Cediranib as Palliative Treatment in Patients With Symptomatic Malignant Ascites or Pleural Effusion [clinicaltrials:NCT01262612]Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites [clinicaltrials:NCT01327235]Video-assisted Hyperthermic Pleural Chemoperfusion vs Talc Pleurodesis for Refractory Malignant Pleural Effusions. [clinicaltrials:NCT01409551]clinicaltrials:NCT01411202clinicaltrials:NCT01612975clinicaltrials:NCT01661790Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural Effusion [clinicaltrials:NCT01670786]clinicaltrials:NCT01766739
condition browse [clinicaltrials_vocabulary:condition-browse]
clinicaltrials:NCT00002622Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions [clinicaltrials:NCT00002872]Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu [clinicaltrials:NCT00004074]clinicaltrials:NCT00042770Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer [clinicaltrials:NCT00052338]Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions [clinicaltrials:NCT00066404]Non-small Cell Lung Cancer Registry [clinicaltrials:NCT00099541]Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion [clinicaltrials:NCT00114205]Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00118183]A Quality of Life Study re Management of Malignant Pleural Effusions [clinicaltrials:NCT00188474]clinicaltrials:NCT00215930clinicaltrials:NCT00231465Comparison the Level of CTGF Protein and Related Cytokine in Pleural Effusion [clinicaltrials:NCT00313066]Multiple Biomarkers in Undiagnosed Pleural Effusion [clinicaltrials:NCT00316134]clinicaltrials:NCT00402896Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00408460]A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis [clinicaltrials:NCT00430664]clinicaltrials:NCT00528645clinicaltrials:NCT00533585clinicaltrials:NCT00564733Tunneled Pleural Catheter in Partially Entrapped Lung [clinicaltrials:NCT00637676]Ibuprofen or Morphine in Treating Pain in Patients Undergoing Pleurodesis for Malignant Pleural Effusion [clinicaltrials:NCT00644319]Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment [clinicaltrials:NCT00752076]A Prospective, Randomized Controlled Trial for a Rapid Pleurodesis Protocol for the Management of Pleural Effusions [clinicaltrials:NCT00758316]Talc Pleurodesis in Patients With Recurrent Malignant Pleural Effusion [clinicaltrials:NCT00789087]The First Therapeutic Intervention in Malignant Pleural Effusion Trial [clinicaltrials:NCT00896285]Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer [clinicaltrials:NCT00897143]clinicaltrials:NCT00978939clinicaltrials:NCT01004510Pleural Catheters Versus Thoracoscopic Pleurodesis [clinicaltrials:NCT01117740]clinicaltrials:NCT01125124clinicaltrials:NCT01256801Cediranib as Palliative Treatment in Patients With Symptomatic Malignant Ascites or Pleural Effusion [clinicaltrials:NCT01262612]Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites [clinicaltrials:NCT01327235]Video-assisted Hyperthermic Pleural Chemoperfusion vs Talc Pleurodesis for Refractory Malignant Pleural Effusions. [clinicaltrials:NCT01409551]clinicaltrials:NCT01411202clinicaltrials:NCT01612975clinicaltrials:NCT01661790Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural Effusion [clinicaltrials:NCT01670786]clinicaltrials:NCT01766739
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Pleural Effusion, Malignant [clinicaltrials_resource:0224c87232a56166bc8710b8dcb1c554]
Bio2RDF identifier
0224c87232a56166bc8710b8dcb1c554
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0224c87232a56166bc8710b8dcb1c554
identifier
clinicaltrials_resource:0224c87232a56166bc8710b8dcb1c554
title
Pleural Effusion, Malignant
@en
type
label
Pleural Effusion, Malignant [clinicaltrials_resource:0224c87232a56166bc8710b8dcb1c554]
@en
Pleural Effusion, Malignant